Calcium-channel modulators for cardiovascular disease.

作者: Théophile Godfraind

DOI: 10.1517/14728214.11.1.49

关键词:

摘要: It is generally accepted that hypertension doubles the risk of cardiovascular disease, which coronary heart disease most common and lethal. Hypertension a predisposing factor for development stroke, peripheral arterial failure end-state renal disease. Atherosclerosis-causing related to severity hypertension. Inhibition calcium entry reduces active tone vascular smooth muscle produces vasodilatation. This pharmacological action has been basis use calcium-channel blockers (CCBs) management Other drug families may achieve this: diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin-receptor antagonists. Cardiovascular hypertrophy atherosclerosis are major complications high blood pressure. Cardiac considered as an independent associated with abnormalities diastolic function can result in failure. Atherosclerosis activation innate immunity. expressing itself not only but cerebrovascular By impairing physiological vasomotor function, includes ultimately necrosis myocardium. CCBs reduce Do they prevent progress main hypertension? question matter present paper.

参考文章(201)
Jan A Staessen, Ji-Guang Wang, Lutgarde Thijs, Calcium-channel blockade and cardiovascular prognosis: recent evidence from clinical outcome trials. American Journal of Hypertension. ,vol. 15, ,(2002) , 10.1016/S0895-7061(02)02949-7
Robert H. Cox, Nancy J. Rusch, New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation. ,vol. 9, pp. 243- 257 ,(2002) , 10.1038/SJ.MN.7800140
Theophile Godfraind, Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries. Journal of Pharmacology and Experimental Therapeutics. ,vol. 224, pp. 443- 450 ,(1983)
William A. Catterall, Structure and regulation of voltage-gated Ca2+ channels. Annual Review of Cell and Developmental Biology. ,vol. 16, pp. 521- 555 ,(2000) , 10.1146/ANNUREV.CELLBIO.16.1.521
Jan A Staessen, Robert Fagard, Lutgarde Thijs, Hilde Celis, Guramy G Arabidze, Willem H Birkenhäger, Christopher J Bulpitt, Peter W de Leeuw, Colin T Dollery, Astrid E Fletcher, Françoise Forette, Gastone Leonetti, Choudomir Nachev, Eoin T O' Brien, Joseph Rosenfeld, José L Rodicio, Jaakko Tuomilehto, Alberto Zanchetti, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension * The Lancet. ,vol. 350, pp. 757- 764 ,(1997) , 10.1016/S0140-6736(97)05381-6
Patricia M Kearney, Megan Whelton, Kristi Reynolds, Paul Muntner, Paul K Whelton, Jiang He, Global burden of hypertension: analysis of worldwide data The Lancet. ,vol. 365, pp. 217- 223 ,(2005) , 10.1016/S0140-6736(05)17741-1
S. E Campbell, Z. Turek, K. Rakusan, S. Kazda, Cardiac structural remodelling after treatment of spontaneously hypertensive rats with nifedipine or nisoldipine Cardiovascular Research. ,vol. 27, pp. 1350- 1358 ,(1993) , 10.1093/CVR/27.7.1350
Phillip F. Pratt, Sebastien Bonnet, Lynda M. Ludwig, Pierre Bonnet, Nancy J. Rusch, Upregulation of L-Type Ca2+ Channels in Mesenteric and Skeletal Arteries of SHR Hypertension. ,vol. 40, pp. 214- 219 ,(2002) , 10.1161/01.HYP.0000025877.23309.36